Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome Advocacy Hub | UniteRare

12.1 Mechanism of Action CRESTOR is an inhibitor of HMG‑CoA reductase, the rate-limiting enzyme that converts 3‑hydroxy‑3‑methylglutaryl coenzyme A to...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome.
Search all trials →

Search clinical trials for Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome →

Recent News & Research

No recent news articles indexed yet for Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome.
Search PubMed for Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome →

Browse all Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome news →

Specialist Network

Top 1 by expertise

Maria Cristina Meriggiola, MD, PhD

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola

📍 Bologna, BO

Score 0

View all Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰